The role of low-income and middle-income country prisons in eliminating hepatitis C
暂无分享,去创建一个
N. Luhmann | J. Cabezas | A. Scheibe | N. Kronfli | P. Chan | M. Akiyama | Y. Sheehan | A. R. Lloyd | Taha Brahni | Kunal Naik | Pelmos Mashabela
[1] A. Lloyd,et al. Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework. , 2021, The lancet. Gastroenterology & hepatology.
[2] H. Razavi. Global Epidemiology of Viral Hepatitis. , 2020, Gastroenterology clinics of North America.
[3] Josephine G. Walker,et al. The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study. , 2019, The lancet. Gastroenterology & hepatology.
[4] Josephine G. Walker,et al. Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis , 2018, The Lancet. Infectious diseases.
[5] S. Basu,et al. Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study. , 2017, The Lancet. Infectious diseases.
[6] M. Mckee,et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees , 2016, The Lancet.